🇺🇸 FDA
Patent

US 6566372

Bicyclic androgen and progesterone receptor modulator compounds and methods

expired A61PA61P13/08A61P15/00

Quick answer

US patent 6566372 (Bicyclic androgen and progesterone receptor modulator compounds and methods) held by Ligand Pharmaceuticals Incorporated expires Mon May 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Ligand Pharmaceuticals Incorporated
Grant date
Tue May 20 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61P, A61P13/08, A61P15/00, A61P15/04, A61P15/08